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Available online 12 April 2016This study combined cytotoxicity assays with proteomic analysis to characterize the unique biological responses
of the A549 human lung epithelial cell line to twophysicochemically distinct respirable particles titaniumdioxide
(TiO2) and carbon black (CB). Cellular LDH, ATP, BrdU incorporation and resazurin reduction indicated that CB
was more potent than TiO2. Proteomic analysis was done using 2D-GE and MALDI-TOF-TOF-MS. Proteomic
changes reﬂected common andparticle-speciﬁc responses. Particle-speciﬁc proteomic responseswere associated
with cell death (necrosis and apoptosis), viability and proliferation pathways. Our results suggested that these
pathways were consistent with the cytotoxicity data. For instance, increased expressions of anti-proliferative
proteins LMNA and PA2G4 were in agreement with the decreased BrdU incorporation in A549 cells after
exposure to CB. Similarly, increased expression of HSPA5 that is associated with ATPase activity was consistent
with decreased cellular ATP levels in these cells. These ﬁndings reveal that proteomic changes can explain the
cellular cytotoxicity characteristics of the particles. In essence, our results demonstrate that the in vitro
toxicoproteomic approach is a promising tool to gain insight into molecular mechanisms underlying particle
exposure-speciﬁc cytotoxicity.
Biological signiﬁcance: In this study we have shown that toxicoproteomics is a sensitive and informative method
to resolve the toxicity characteristics of particles with different physicochemical properties. This approach can be
useful in the investigation of molecular mechanisms underpinning cellular cytotoxic responses elicited by
particle exposures. Thus, the toxicoproteomic approach can be valuable in assessing the risk associated with
particle exposures in vitro.
Crown Copyright © 2016 Published by Elsevier B.V. This is an open access article under the CC BY license
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Titanium dioxide
Carbon black
A549
Toxicoproteomics
Cytotoxicity assay
2D-GE1. Introduction
Airborne particulate matter (PM) is a complex mixture of inor-
ganic and organic compounds. Inhalation of airborne PM has been
linked to the development or exacerbation of respiratory illnesses
such as bronchitis [1–3], asthma [4–6], cystic ﬁbrosis [7,8] and lung
cancer [2,9–12].Toxicity of urban air particles and their associated
adverse health outcomes can vary with particle composition. Insight
into particle exposure-speciﬁc molecular mechanisms can provide a
biological basis of particle toxicity. In this study, we focused on antawa, ON, Canada.
a (P. Kumarathasan).
r B.V. This is an open access article uin vitro toxicoproteomic approach that can distinguish the toxic ef-
fects of two particles that are chemically and physically different.
Carbon black (CB) is a manufactured product containing predomi-
nantly (95%) elemental carbon (EC) with negligible amounts of
inorganic and organic materials [13,14] and should not be confused
with black carbon (soot) that contains varying amounts of EC, organic
materials andmetals [14,15]. Recent reports have implied that exposure
to elemental carbon (EC) can have a negative impact on the cardiovas-
cular system [16–19]. Yet, toxicity mechanisms underpinning EC
exposure-related adverse cardiovascular effects are not clear, and CB
has been used as a surrogate for EC in in vitro and in vivo toxicity studies
[20–25]. Meanwhile, titanium dioxide (TiO2) is typically used as a
“negative control” in many particle toxicology studies due to its relative
low toxicity properties both in vivo and in vitro. Nevertheless, recent
studies have reported that the toxicity of TiO2 could depend onnder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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surface modiﬁcations [26].
Cytotoxicity of particles has traditionally been assessed by endpoint
assays such as resazurin reduction, cellular ATP, lactate dehydrogenase
(LDH) release and 5-bromo-2′-deoxyuridine (BrdU) incorporation.
These assays are attractive to researchers because they can be applied
in a high-throughputmanner to estimate the toxic potency of respirable
particles. One of the drawbacks of these cytotoxic assays is that they do
not reveal detailed information at the molecular level. In recent years,
proteomic-based approaches have gained momentum in toxicology
based on their ability to delineate themolecularmechanism underlying
the toxicity of PM [27,28]. Protein separation by two-dimensional gel
electrophoresis (2D-GE) followed by protein identiﬁcation by mass
spectrometry (MS) or tandemmass spectrometry (MS/MS) is a classical
proteomic approach used to quantify and identify proteins in complex
biological matrices. While shot-gun proteomic analyses (using MALDI-
TOF-TOF/MS/MS or LC/MS/MS) are proposed alternatives to gel-based
proteomic procedures, the advantage of 2D-GE is that it is relatively in-
expensive and can provide high content data. Recent studies have used
2D-GE to identify proteomic changes in cells to help characterize the
toxicity caused by exposure to particles [27,29–34].
In this study, in order to understand particle-speciﬁc cellular
changes we exposed a human lung epithelial cell line (A549) to two
chemically and physically different respirable materials, CB and TiO2
particle. We then used a toxicoproteomic approach by conducting
traditional cytotoxicity assays along with proteomics to identify the
molecular signature of particle toxicity.
2. Materials and methods
2.1. Materials
Culture ﬂasks (T-25 and T-75), 96-well plate and plastic cell scrapers
were obtained from Corning Inc. (Corning, NY). Dulbecco's Modiﬁed
Eagle's Medium (DMEM) and fetal bovine serum (FBS) were purchased
from HyClone (Logan, UT). Gentamicin, triﬂuoroacetic acid,α-cyano-4-
hydroxy-cinnamic acid, Tris-HCl, NaCl, Tween-20 and Tween-80 were
obtained from Sigma-Aldrich (Oakville, ON). Iodoacetamide, bis-
acrylamide, ammonium persulfate, glycerol, immobilized pH gradient
strips, Criterion Cassette (13.3 × 8.7 cmW× L), Tris/Glycine/SDS buffer,
and BioSafe Coomassie Blue were purchased from Bio-Rad (Mississau-
ga, ON). Trypsin, resazurin reduction (CellTiter-Blue®) and lactate
dehydrogenase (LDH) cytotoxicity assay kits (CytoTox-96®) were
from Promega Corporation (Madison, WI), ATP assay kit (ViaLight™
Plus) was purchased from Lonza Corporation (Rockland, ME), and 5-
bromo-2′-deoxyuridine (BrdU) cell proliferation ELISA (chemilumines-
cent) assay kit was obtained from Roche Diagnostics (Laval, QC). All
water used was deionized/demineralized (N16 MΩ resistivity).
2.2. Particles preparation
TiO2 (SRM-154b) obtained from the National Institute of Standards
and Technology (Gaithersburg, MD) was subjected to three successive
washes with methanol and then phosphate buffered saline (PBS) to
remove possible soluble metals and organic contaminants before use
in the experiments [35]. Carbon black (Cas#1333-86-4) obtained from
Cabot Corporation (Boston, MA) was used as received. Particles were
resuspended at 10 mg/mL in particle buffer (0.19% NaCl and 25 μg/mL
Tween-80) [36], vortexed (30 s), sonicated (20 min on ice), homoge-
nized with a Dounce Homogenizer (25 strokes), and then heated
(56 °C, 1 h). The particles were stored at−40 °C until use.
2.3. Cell culture and particle exposure
The A549 cell line (American Type Culture Collection - CCL-185;
human, epithelial, lung carcinoma) was subcultured in DMEMsupplemented with 50 μg/mL gentamycin and 10% FBS. The cells were
maintained in T-75 ﬂasks in a humidiﬁed atmosphere at 37 °C containing
5% CO2 and 95% air. For experiments, the cells were seeded at 1.5 × 106
cells (T-25), 3.75 × 106 cells (T-75) or 2.0 × 104 cells/well (96-well
plate for cytotoxicity assays) and incubated for 24 h, resulting in approx-
imately 75% conﬂuence prior to dosingwith particles. The ﬁnal volume of
culture medium was 5 mL (T-25), 15 mL (T-75) or 200 μL/well (96-well
plate). Solutions of particles were prepared by thawing the frozen stocks
to aqueous solutions, sonicating on ice (20 min) then diluting in the cul-
ture medium to make up dosing concentrations of 0, 60, 140 and
200 μg/cm2. The cells were exposed to the particles by replacing the
existing culture mediumwith the particle solutions, and the ﬂasks/plates
were returned to the incubator and allowed to incubate for 24 h. To har-
vest the exposed cells, the medium in each ﬂask was removed and the
cells were detached from the ﬂasks using a plastic scraper. The cell sus-
pension was collected in cell culture medium and centrifuged at 350 ×g
for 5 min, and the supernatant was removed. The cell pellet was then
washed twice with PBS. The ﬁnal cell pellet was aspirated dry and stored
frozen at−80 °C until further use. The integrated cytotoxicity bioassay
which combined endpoints of cell viability (resazurin reduction assay),
cellular membrane integrity (intracellular LDH content) and energy me-
tabolism (ATP assay) were conducted in 96-well plates as described in
our previous study [37]. The cell proliferation (BrdU incorporation)
assay was conducted in a separate 96-well plate.
2.4. Protein extraction
The cell pellets were solubilized in a protein extraction/rehydration
buffer from Bio-Rad (8 M urea, 2% CHAPS, 50 mM dithiothreitol, 0.2%
Biolyte 3/10), where the volume depends on the number of cells in
the pellet to achieve 1–2 μg/μL, and 1 × 106 A549 cells was experimen-
tally estimated to yield about 200 μg of protein. The samples were
vortexed (30 s), sonicated (10 min), vortexed (30 s) and centrifuged
(15,000 ×g, 10 min). The extracted protein in the supernatant was
collected, and the concentration of protein in each extract was
determined immediately using the Coomassie Plus Protein assay kit
(Thermo Scientiﬁc). The extracted protein samples were stored at
−80 °C until use.
2.5. Two-dimensional gel electrophoresis (2D-GE)
2D-GEwas conducted as described in our previous study [38]. Brieﬂy,
an appropriate quantity of protein was suspended in a total volume of
200 μL of extraction buffer, and applied to an immobilized pH gradient
(IPG) strips (11 cm, pH 3–10 or pH 5–8) in a clean disposable rehydration
tray and allowed to incubate for 1 h at room temperature. The IPG strip
was then overlaid with mineral oil and allowed to continue incubating
overnight (16–20h). The IPG stripwas thenmoved to an isoelectric focus-
ing tray, overlaid with mineral oil and subjected to isoelectric focusing
using a PROTEAN IEF cell (BioRad). The focusing conditions were as fol-
lows: stage 1: linear ramp to 250 V for 20 min; stage 2: linear ramp to
8000 V for 2.5 h; stage 3: rapid ramp for 20,000 V h. The strip was then
stored at−80 °C until use. The focused IPG strip was thawed and gently
agitated for 10 min in equilibration buffer 1 (6 M urea, 2% SDS, 375 mM
Tris-HCl, 20% glycerol, 130 mM dithiothreitol, 0.001% bromophenol
blue). Then each stripwas gently agitated for another 10min in equilibra-
tion buffer 2 (6 M urea, 2% SDS, 375 mM Tris-HCl, 20% glycerol, 135 mM
iodoacetamide, 0.001% bromophenol blue). The strip was then placed on
a 12% SDS-PAGE gel casted in a 1.0 mm thick Criterion Cassette
(13.3 × 8.7 cm W × L) and subjected to electrophoresis at 200 V for
65 min. Following electrophoresis, the gel was removed from the Criteri-
on Cassette, washed for 30 min in water, stained in BioSafe Coomassie
Blue (Bio-Rad) overnight (16–20 h), destained twice in water, and then
imaged with a standard scanner.
To overcome the typical warping and distortion issues from gel to
gel near the extremities of the pH and the molecular weight range, a
Fig. 2. Selection of the information-rich region in the two-dimensional gel electrophoresis (2D-GE) map of A549 proteins to investigate particle exposure-related changes.
Fig. 1. The cytotoxicity of titaniumdioxide and carbon black in A549 cells after 24 h of exposure were examined by cellular LDH (A), BrdU incorporation (B), cellular ATP (C) and resazurin
reduction (D) assays. Data are expressed as mean fold effect ± standard error, relative to control (0 μg/cm2), n = 4. Two-way ANOVA was used to determine signiﬁcant effects of the
particles, where Holm-Sidak was the post-hoc method used for all pairwise comparison procedures. * indicates a signiﬁcant change (p b 0.05) compared to control (0 μg/cm2) and †
indicates signiﬁcant differences between the two particles.
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the protein spots across all experimental gels was selected to assess
the proteome differences among the treatments. The protein spots
within the gels were matched and quantiﬁed with PDQuest™ Advance
V8.0.1 (Bio-Rad), where spot volumewas quantiﬁed using the available
“Local regression model (LOESS)” algorithm in PDQuest. The reported
normalized spot volume for each protein was used to compare its
level of expression across the treatments. Three gels representing
three biological repeats were generated for each group in this
experiment to assess the particle-induced changes in the proteome of
A549 cells.2.6. In-gel digest, preparing protein spots for identiﬁcation
To identify the protein in each spot of interest, a large set of prepar-
ative gels (10–12 gels) were prepared with 175 μg of protein/gel as de-
scribed above. The gels were then stained with Biosafe Coomassie blue
and imaged. The spots in preparative gels were then aligned and
matched to the experimental gels using PDQuest. The protein spots
were then excised from the preparative gels with an automated spot
cutter equipped with a 1.5 mm cutting head (ExQuest from Bio-Rad).
The excised gels corresponding to the same protein spot from different
preparative gels were pooled into the same tube for maximum protein
yield. The excised gels were then subjected to in-gel tryptic digest as
described in our previous study [38]. Brieﬂy, the gel spots were
destained and then subjected to a 16 h digestion by trypsin (pH = 7)
at 37 °C. All the digested samples were evaporated under a gentle
stream of N2(g) and were stored at−80 °C until further use.Fig. 3. 2D-GEmap of proteins inA549 cells used for further protein identiﬁcation bymass spectr
of the “Data in Brief” article [42] submitted along with this manuscript.2.7. Matrix-assisted laser desorption/ionization time-of-ﬂight mass
spectrometry (MALDI-TOF-TOF-MS)
Each sample was reconstituted in 5 to 20 μL of 30% acetonitrile (ACN)
in 0.1% triﬂuoroacetic acid (TFA) depending on the spot volume and was
spotted (1.5 μL) on an AnchorChip target plate (600/384F, Bruker
Daltonics Ltd, Bremen, Germany) together with 1.5 μL of freshly prepared
α-cyano-4-hydroxy-cinnamic acid (5 μg/μL in 50% ACN in 0.1% TFA). The
spotted sample/matrix was dried under vacuum for at least 2 h. Each
dried sample/matrix was washed with 2.5 μL of cold 0.1% TFA and brieﬂy
dried under vacuum. Each sample was analyzed by MALDI-TOF-TOF-MS
using an automated analysis option (Bruker Daltonics, Bremen,
Germany). In brief, MS scan of each spot was done to obtain the peptide
mass ﬁngerprint (PMF). Six major analyte peaks from the PMF spectrum
were subjected to tandem MS (MS/MS) analysis in the “voltage lift
mode”. Themass spectral informationwasmatched against the SwissProt
and RefSeq data bases using the Mascot search engine (Matrix Sciences)
for protein identiﬁcation. In the case that N1 protein was identiﬁed per
spot, we attributed the protein with the highest score to such spot.2.8. Statistics and bioinformatics
Two-way analysis of variance (ANOVA)was performed on 2D-GE and
cytotoxicity (LDH, BrdU, ATP and CTB) data with treatment and dose as
factors. When the assumption of equal variance and normal distribution
were not met, the data were rank-transformed. Holm-Sidak was the
post-hoc method used for all pairwise comparison procedures. A data
point is considered as signiﬁcant if p b 0.05. If the Treatment x Doseometry. The numbers in themap correspond to the identiﬁedprotein spots listed in Table 2
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given treatment and dose that was found signiﬁcant by Holm-Sidak anal-
ysis was reported as it is, as seen in Table 2. The same applied for those
proteins that were found to have signiﬁcant Treatment and Dosemain ef-
fects. If a proteinwas found to have signiﬁcant Treatmentmain effect, fold
changes were estimated using least mean square [39,40]. In the case
where the Dosemain effect was signiﬁcant, the average fold change esti-
matewas reported for each signiﬁcant dose group. It should be noted that
multiple protein spots with the same protein ID may have a p-
value b 0.05, which suggests different isoforms of the same protein
were signiﬁcantly altered, and thus rigorous assessment may be required
for proper interpretation of biological implication if the directions of
change of these isoforms are different. However, our data showed that
the direction of expression of all signiﬁcant protein spots with the same
ID aligned in the same direction, thus we chose the protein with the
greatest fold-change (either increase or decrease) to conduct pathway
analysis. Protein interaction network and pathway analyses were con-
ducted by Ingenuity Pathway Analysis (www.ingenuity.com). Venn dia-
grams used to assess the similarities and/or differences in the protein
proﬁle following particle exposures were generated via VENNY [41].Table 1
Two-way ANOVA results for the A549 protein spot changes due to particle exposures (n=3). Th
corresponds to thep-value,where the boldnumber is b0.05. The number below theparticles cor
identiﬁed by MALDI-TOF-TOF-MS are provided here.
Two-way ANOVA TiO
SSP Protein Trt Dose T × D 60
3202 CAPZA1 0.004 0.016 0.031
9804 FUBP1 0.039 0.947 0.044
7701 CCT6A 0.507 0.031 0.034
8501 EEF2 0.571 0.004 0.020
6501 PA2G4 0.165 0.023 0.047
7501 PA2G4 0.953 0.009 0.037
1602 TUBA1C 0.793 0.015 0.049
2902 VCP 0.457 0.002 0.024
7603 ALDH1A1 0.096 0.131 0.034
6604 CCT2 0.792 0.237 0.023
4702 PDIA3 0.368 0.220 0.021
3207 TRIM28 0.192 0.096 0.035
4102 VCP 0.554 0.083 0.036
2006 CRK b0.001 b0.001 0.085 1
8205 AKR1A1 0.041 0.431 0.395
102 HSPA5 0.017 0.134 0.441
8809 LMNA 0.028 0.311 0.303 −1
2301 TMOD3 0.005 0.201 0.139 −1
6502 ANXA7 0.124 0.037 0.502
8108 ARMCX1 0.472 0.017 0.379
9502 DIS3L 0.298 0.000 0.504
8107 EEF2 0.580 0.031 0.719
7205 ENO1 0.723 0.021 0.416
8503 ENO1 0.413 0.035 0.561
9405 ENO1 0.876 0.043 0.593
5607 HNRNPH1 0.852 0.022 0.458
2701 HNRNPK 0.913 0.020 0.146
3104 HSP90AB3P 0.568 0.026 0.615
8106 HSPA8 0.622 0.035 0.533
8117 IDH1 0.899 0.014 0.443
5902 IMMT 0.510 0.019 0.761 1
3705 INA 0.967 0.002 0.084
8103 NIT2 0.410 0.017 0.797
8110 PDIA3 0.270 0.029 0.580
6306 PGK1 0.363 0.034 0.282
7204 PKM 0.431 0.003 0.922
8606 PKM 0.942 0.026 0.889
5105 PSMB7 0.367 0.019 0.466
8301 RBM4 0.676 0.038 0.402 1
8308 RBM4 0.708 0.025 0.634
2904 VCP 0.745 0.004 0.141
5301 XXYLT1 0.131 0.008 0.499 13. Results
3.1. Cytotoxic assays
Cellular LDH levels (Fig. 1A) were found to decrease with particle
dose (Two-way ANOVA: Dose main effect, p b 0.05; Holm-Sidak: 140,
200 vs 0 μg/cm2, p b 0.05). Reduction in cytoplasmic LDH was more
pronounced after exposure to CB than with TiO2, but this difference
did not reach statistical signiﬁcance. Cellular proliferation measured
by BrdU incorporation (Fig. 1B) was decreased by exposure to CB, but
not with TiO2 (Fig. 1B; Two-way ANOVA, Treatment × Dose interaction,
p b 0.05; Holm-Sidak: 60, 140, 200 vs 0 μg CB/cm2, p b 0.05). Decrease of
cellular ATP (Fig. 1C) was statistically signiﬁcant for treatment (Two-
way ANOVA, Treatment main effect, p b 0.05; Holm-Sidak: CB vs TiO2,
p b 0.05) and dose (Two-way ANOVA, Dose main effect, p b 0.05;
Holm-Sidak: 200 vs 0 μg/cm2, p b 0.05). Resazurin reduction assay
(Fig. 1D) revealed a Treatment × Dose interaction (Two-way ANOVA:
Treatment × Dose, p b 0.05; Holm-Sidak, 60, 140 & 200 vs 0 μg/cm2,
p b 0.05), where only CB, but not TiO2, signiﬁcantly increased the reduc-
tion of resazurin.enumber below Treatmentmain effect (Trt),Dosemain effect (Dose) or interaction (T×D)
responds to the adjusted fold change (versus control) of the protein. Only theprotein spots
2 (μg/cm2) CB (μg/cm2)
140 200 60 140 200
1.15
1.29 −1.41
1.51
3.00 −2.63
1.40
1.49
2.43
1.63
−1.61
−1.24 1.53
1.45
1.49 −1.44
−1.35
.29 1.77 1.44 4.28 6.20 5.93
1.33 1.33 1.33
1.51 1.51 1.51
.10 −1.10 −1.10 1.19 1.19 1.19
.19 −1.19 −1.19 1.28 1.28 1.28
1.32 −1.68 1.32 −1.68
1.88 1.88
−1.52 −1.52
1.52 −1.30 1.52 −1.30
1.59 −1.18 1.59 −1.18
1.32 −1.29 1.32 −1.29
1.57 −1.26 1.57 −1.26
−1.33 1.35 −1.33 1.35
−1.77 −1.77
1.56 −1.15 1.56 −1.15
1.51 −1.07 1.51 −1.07
1.58 −1.37 1.58 −1.37
.35 −1.38 1.35 −1.38
2.16 1.72 2.16 1.72
1.26 −1.11 1.26 −1.11
1.53 −2.30 1.53 −2.30
1.27 −1.43 1.27 −1.43
−1.86 −1.86
−1.68 −1.68
1.38 1.38
.65 1.65
−1.27 −1.27
−2.23 −2.23
.24 1.19 1.26 1.24 1.19 1.26
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It was experimentally determined that approximately 200 μg of pro-
tein can be extracted from 1 × 106 A549 cells. The protein proﬁle of the
A549 cells was initially evaluated with two pH ranges (pH 3–10 and
pH 5–8) in the ﬁrst dimension, while keeping the second dimension
constant (12% SDS-PAGE). The 2D gel image in Fig. 2A showed that
the pH 3–10 range encompassed most of the proteins detected by
Coomassie blue. The pH 5–8 range gel detected approximately 85% of
the proteins thatwere found in the pH 3–10 range (Fig. 2B). The protein
spots in the pH 5–8 range were notably better resolved than that of
pH 3–10. For this reason, the pH 5–8 range and 12% SDS-PAGE were
selected to examine changes in the proteome of A549 cells following
particle exposure. It was determined that when using 11 cm, pH 5–8
IPG strips, the optimal protein loading to visualize Coomassie Blue
stained protein spots was between 100 and 175 μg (data not shown),
as lower protein amounts resulted in missing spots, and higher protein
loading led to poor resolution between spots due to the limited separa-
tion capacity of the 11 cm IPG strip. Coomassie blue stain was chosen
since it is economical for the purpose of large toxicity screening studies
and it is also compatible with MALDI-TOF-TOF-MS.
To assess the A549 proteome differences due to particle exposures, a
common area that clearly displayed the majority of protein spots was
employed across all experimental gels (Fig. 2B). This area (between
pH 5.1–7.8 and 20–100 kDa) was chosen to overcome the typical
warping, distortion and variation that were commonly encountered
with 2D gels, particularly near the extremities of the molecular weight
and pH range. Of the 543 protein spots detected in the common areaFig. 4. Two-way ANOVA results of differentially expressed proteins (p-value b0.05) in A549 ce
shows the number of proteins which increased or decreased in expression following particle t
proteins that exhibited speciﬁc and non-speciﬁc changes due to particle exposures. (C) Tabu
proteins that were identiﬁed by MALDI-TOF-TOF-MS/MS are shown. ↑ indicates increased exprof the gels, 333 spots were identiﬁed with MALDI-TOF-TOF-MS/MS
(Fig. 3 and Table 2 in the related “Data in Brief” article [42]). In many
cases, the same protein was detected in multiple spots; these multiple
IDs (likely representing post-translational modiﬁcations, isoforms or
degradation products) are summarized in Table 2 in the related “Data
in Brief” article. In total, the 2D-GE map resulted in the identiﬁcation
of 180 unique proteins.
3.3. PM-induced changes in the proteome of A549 cells
Analysis of proteomic changes due to particle exposures revealed
that the expressions of 60 protein spots were affected by both TiO2
and CB, of which 42 protein spots were identiﬁed by MALDI-TOF-TOF-
MS (Table 1). For proteins represented by multiple spots, the spot
with the greatest fold changewas selected for pathway analysis asmen-
tioned in the Materials and Methods. Particle dose-related changes
were noticed in 24 protein spots (Two-way ANOVA: Dosemain effect,
p b 0.05), 20 ofwhich are unique proteins. Particle type-speciﬁc changes
were noticed in 5 protein spots (Two-way ANOVA: Treatmentmain ef-
fect, p b 0.05), all of which are unique proteins; while 13 protein spots
exhibited Treatment × Dose interaction (Two-way ANOVA:
Treatment× Dosemain effect, p b 0.05), 12 of these are unique proteins.
Fig. 4A illustrates the effect of TiO2 and CB exposures on A549 cellular
proteome, where the particles up- and down-regulated the expression
of proteins. The proteins that were affected commonly by both particle
exposures and particle-speciﬁc alteration are shown in Fig. 4B and C.
Protein interaction network and pathway analyses revealed that all
the proteins (common and unique) affected by the two particles werells following exposures to carbon black (CB) or titanium dioxide (TiO2). (A) The bar graph
reatments at doses 60, 140 and 200 μg/cm2. (B) The Venn diagram shows the number of
lation of unique and common proteins associated with CB and TiO2 exposures. Only the
ession and ↓ speciﬁes decreased expression.
Table 2
All A549 proteins that exhibited altered expressions (fold change compared to control) due to particle exposures and relevant cellular functions using Ingenuity Pathway Analysis.
Cellular TiO2 (μg/cm2) CB (μg/cm2)
Function 60 140 200 60 140 200
Cell death (apoptosis & necrosis)
ALDH1A1 −1.61
ANXA7 1.32 −1.68 1.32 −1.68
ENO1a 1.57 −1.26 1.57 −1.26
FUBP1 1.29 −1.41
CRK 1.29 1.77 1.44 4.28 6.20 5.93
HNRNPH1 −1.33 1.35 −1.33 1.35
HNRNPK −1.77 −1.77
HSPA5 1.51 1.51 1.51
HSPA8 1.51 −1.07 1.51 −1.07
IMMT 1.35 −1.38 1.35 −1.38
LMNA −1.10 −1.10 −1.10 1.19 1.19 1.19
PA2G4a 1.49
PDIA3a 1.53 −2.30 1.53 −2.30
PKMa −1.86 −1.86
TMOD3 −1.19 −1.19 −1.19 1.28 1.28 1.28
TRIM28 1.49 −1.44
VCPa −2.23 −2.23 1.63
CCT6A 1.51
CCT2 −1.24 1.53
Inﬂammation
AKR1A1 1.33 1.33 1.33
ANXA7 1.32 −1.68 1.32 −1.68
EEF2a 3.00 −1.30 1.52 −2.63
ENO1a 1.57 −1.26 1.57 −1.26
FUBP1 1.29 −1.41
HSPA5 1.51 1.51 1.51
HSPA8 1.51 −1.07 1.51 −1.07
PDIA3a 1.53 −2.30 1.53 −2.30
PGK1 1.27 −1.43 1.27 −1.43
PKMa −1.86 −1.86
TRIM28 1.49 −1.44
TUBA1C 2.43
VCPa −2.23 −2.23 1.63
Protein metabolism
CRK 1.29 1.77 1.44 4.28 6.20 5.93
EEF2a 3.00 −1.30 1.52 −2.63
HNRNPK −1.77 −1.77
HSPA5 1.51 1.51 1.51
PDIA3a 1.53 −2.30 1.53 −2.30
RBM4a 1.65 −1.27 1.65 −1.27
VCPa −2.23 −2.23 1.63
Cell survival & viability
EEF2a 3.00 −1.30 1.52 −2.63
IDH1 1.58 −1.37 1.58 −1.37
LMNA −1.10 −1.10 −1.10 1.19 1.19 1.19
PDIA3a 1.53 −2.30 1.53 −2.30
PKMa −1.86 −1.86
TRIM28 1.49 −1.44
HSPA5 1.51 1.51 1.51
VCPa −2.23 −2.23 1.63
Cell proliferation
ANXA7 1.32 −1.68 1.32 −1.68
ENO1a 1.57 −1.26 1.57 −1.26
CRK 1.29 1.77 1.44 4.28 6.20 5.93
HNRNPK −1.77 −1.77
HSPA8 1.51 −1.07 1.51 −1.07
IDH1 1.58 −1.37 1.58 −1.37
IMMT 1.35 −1.38 1.35 −1.38
LMNA −1.10 −1.10 −1.10 1.19 1.19 1.19
PDIA3a 1.53 −2.30 1.53 −2.30
PGK1 1.27 −1.43 1.27 −1.43
VCPa −2.23 −2.23 1.63
ALDH1A1 −1.61
CCT2 −1.24 1.53
DIS3L −1.52 −1.52
PKMa −1.86 −1.86
TRIM28 1.49 −1.44
HSPA5 1.51 1.51 1.51
CAPZA1 1.15
PA2G4a 1.49
(continued on next page)
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Table 2 (continued)
Cellular TiO2 (μg/cm2) CB (μg/cm2)
Function 60 140 200 60 140 200
Cell migration
CRK 1.29 1.77 1.44 4.28 6.20 5.93
ENO1a 1.57 −1.26 1.57 −1.26
HNRNPK −1.77 −1.77
HSPA5 1.51 1.51 1.51
IDH1 1.58 −1.37 1.58 −1.37
LMNA −1.10 −1.10 −1.10 1.19 1.19 1.19
PA2G4a 1.49
PDIA3a 1.53 −2.30 1.53 −2.30
PKMa −1.86 −1.86
TMOD3 −1.19 −1.19 −1.19 1.28 1.28 1.28
TUBA1C 2.43
VCPa −2.23 −2.23 1.63
a Protein represented by multiple spots. The spot with the highest fold change was used as mentioned in the Materials and Methods.
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liferation,migration, proteinmetabolism, inﬂammation and survival/vi-
ability pathways (Table 2). To determine the toxicoproteomic
differences between TiO2 and CB, the proteins that were differentially
affected by the two particles were interrogated; these proteins were
highlighted in Table 1 that two-way ANOVA identiﬁed as signiﬁcant
for interaction and treatment main effects. The results in Table 3 show
that the differential toxicoproteomic effect between TiO2 and CB lies
mainly in those proteins that regulate proliferation, viability, apoptosis
and necrosis in cells. Fig. 5 shows that there were distinctive patterns
of protein expression in A549 cells in response to the two particles as
demonstrated in the networks of cell death (apoptosis and necrosis)
and cell proliferation pathways.Table 3
A549 proteins that are differentially affected by TiO2 and CB and associated cellular func-
tions. The proteins in this table were identiﬁed by two-way ANOVA as Treatmentmain ef-
fect and Treatment × Dose interaction, which were highlighted in Table 1.
Cellular TiO2 (μg/cm2) CB (μg/cm2)
Function 60 140 200 60 140 200
Cell death (apoptosis & necrosis)
ALDH1A1 −1.61
CCT2 −1.24 1.53
CCT6A 1.51
FUBP1 1.29 −1.41
CRK 1.29 1.77 1.44 4.28 6.20 5.93
HSPA5 1.51 1.51 1.51
LMNA −1.10 −1.10 −1.10 1.19 1.19 1.19
PA2G4a 1.49
TMOD3 −1.19 −1.19 −1.19 1.28 1.28 1.28
TRIM28 1.49 −1.44
VCPa −2.23 −2.23 1.63
Cell viability
EEF2 3.00 −1.30 1.52 −2.63
HSPA5 1.51 1.51 1.51
LMNA −1.10 −1.10 −1.10 1.19 1.19 1.19
TRIM28 1.49 −1.44
VCPa −2.23 −2.23 1.63
Cell proliferation
ALDH1A1 −1.61
CAPZA1 1.15
CCT2 −1.24 1.53
CRK 1.29 1.77 1.44 4.28 6.20 5.93
HSPA5 1.51 1.51 1.51
LMNA −1.10 −1.10 −1.10 1.19 1.19 1.19
PA2G4a 1.49
TRIM28 1.49 −1.44
VCPa −2.23 −2.23 1.63
a Protein represented bymultiple spots. The spotwith the highest fold changewas used
as mentioned in the Materials and Methods.4. Discussion
In this work, we utilized a well-established human lung epithelial
cell line (A549) to assess the effects of CB and TiO2, two respirable
particles with distinct chemical and physical properties. Decrease of
the cytoplasmic LDH content is suggestive of alteration of cell
membrane integrity. BrdU incorporation, which assesses DNA synthesis
during cell proliferation, was reduced with increasing doses of CB but
not TiO2. Cellular energy metabolism investigated by the ATP assay
demonstrated that both particles reduced the level of ATP in A549
cells, with CB being more potent than TiO2. In the resazurin reduction
assay, CB but not TiO2 increased the rate of reduction. In short, the
results from the cytotoxicity assays indicate that A549 cells were
reactive to the particles,with CB beingmore potent than TiO2 in eliciting
cellular responses, but both particles were mildly cytotoxic under the
experimental conditions with a cellular viability greater than 75% at
the highest exposure level tested.
Cellular proteomic changes were analyzed by 2D-GE followed by
protein identiﬁcation using mass spectrometry. We chose to examine
the A549 proteome in the window of pH 5.2–pH 7.8 and 100–20 kDa
because this area contained most of the protein spots (543) that were
well-resolved across all experimental gels (Fig. 2B). Of the 543 protein
spots, we have determined the identities of 333 protein spots via
MALDI-TOF-TOF-MS/MS, and to our knowledge this is the largest
repository of A549 cellular proteome identiﬁed by 2D-GE thus far. It
should be noted that the same protein was detected in multiple spots
in many cases (Table 2 in the related “Data in Brief” article [42]),
where these multiple IDs are likely representing post-translational
modiﬁcations, isoforms or degradation products of the same protein.
Two-way ANOVA revealed that 60 of the protein spots showed
signiﬁcant changes (p b 0.05) as Treatment or Dose main effects, and
with Treatment × Dose interaction following exposure of cells to TiO2
and CB (Table 1). Fig. 4A illustrates the effect of TiO2 and CB exposureson A549 cellular proteome, where the particles up- and down-
regulated the expression of proteins. This ﬁgure showed that
140 μg/cm2 doses led to increased expression of more proteins relative
to both 60 and 200 μg/cm2 doses. These ﬁndings can potentially be
attributed to non-monotonous toxicity effects. It is possible that the
medium dose (140 μg/cm2) enhanced protein synthesis as a response
to increased toxicity compared to the low dose, whereas at the highest
toxic dose (200 μg/cm2), reduced protein synthesis and enhance protein
degradation can occur as a result of cellular apoptosis.
It should be noted that the signiﬁcant cut-off p-value was set at 0.05,
it is possible that 27 signiﬁcant spots (5% of 543 protein spots
examined) could be false positive by random chance. However, proteins
do not act on their own in a cell, they normally interact with one
61N.Q. Vuong et al. / Journal of Proteomics 149 (2016) 53–63another in a network or pathway to carry out a particular function. Thus,
when a group of proteins in a particular pathwaywere identiﬁed as sig-
niﬁcantly altered with unadjusted p-value b 0.05, we posit that changes
in a group of proteins are not likely to occur by random chance. There-
fore, we decided to retain the 60 signiﬁcant protein spots with p-
value b 0.05 (not adjusted for false discovery), and the identities of 42
of these spots have been determined via MALDI-TOF-TOF-MS (Fig. 4
and Table 1). In pathway analysis, only those pathways that were inﬂu-
enced by N5 signiﬁcant proteins in any treatment were ﬂagged as pos-
sible pathways that were affected by exposure treatments.
Ingenuity pathway analysis revealed that TiO2 and CB can
signiﬁcantly alter the expression of proteins that are known to be in-
volved in inﬂammation, protein metabolism, cell migration, prolifera-
tion, death and survival (Table 2). Although the use of all signiﬁcant
proteins for pathway analysis gave an overall idea of the cellular func-
tions that can be affected by both particles, in order to dissect theFig. 5. The networks of cell death (apoptosis and necrosis) and cell proliferation pathways that
(Table 3). Red is for increased expression and green is for decreased expression.toxicoproteomic differences between TiO2 and CB, we selected the pro-
teins that were unique to TiO2 and CB exposures for pathway analysis
(Table 3). The results in Table 3 demonstrated that the proteins that reg-
ulate cell proliferation, viability, apoptosis and necrosiswere affected by
TiO2 and CB differently. Nevertheless, the number of proteins that are
unique to these pathways was found to be low. For instance, CCT6A,
EEF2 and CAPZA1were unique to cell death, cell viability and cell prolif-
eration respectively, while the others were common to all three path-
ways. Even though it is possible that there can be network ambiguity
through IPA analyses, the signiﬁcant proteins that were affected by
both particles in Table 2 showed more unique proteins speciﬁc to cell
death (e.g., CCT6A, FUBP1, HNRNPH1 and TMOD3) and cell proliferation
(e.g., CAPZA1, DIS3L and PGK1) pathways. In addition, the cytotoxicity
assay results are indicative of induced cell death (decreased cellular
LDH and ATP levels) and decreased cell proliferation (decreased BrdU
incorporation) pathways upon particle exposures. Together, theseemphasize the toxicoproteomic differences between TiO2 and CB at the dose 200 μg/cm2
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cell viability and cell proliferation pathways in the A549 cells.
The networks of protein-protein interaction in Fig. 5 showed how
the two particles distinctively affected those proteins involved in cell
death and proliferation pathway. In the network of cell proliferation,
TiO2 speciﬁcally increased the expression of TRIM28 and decreased
the expression of ALDH1A1, CCT2 and LMNA, while CB speciﬁcally
decreased the expression of TRIM28 and increased the expression of
CAPZA1, CCT2, HSPA5, LMNA, PA2G4 and VCP. The serine/threonine
kinase Akt is a well-recognized signaling hub that orchestrates various
cellular functions (including cell growth and survival) and this protein
interacts directly and indirectly with the majority of the proteins that
were up-regulated only by CB treatments (Fig. 5). It would be interest-
ing to examine the time-related functional interactions between Akt
and these proteins. For example, the level of LMNA is reportedly
regulated by the serine/threonine kinase Akt in C2C12mousemyoblasts
and HEK293 human embryonic kidney epithelial cells [43], where Akt
can phosphorylate LMNA and targets it for degradation through a
lysosomal mechanism [43], and Akt can also regulate the transcription
of LMNA [43]. Since LMNA is an intermediate ﬁlament protein in the
nuclear lamina that must be degraded for DNA synthesis and mitosis
to occur, an increase in LMNA expression in A549 cells exposed to CB
can be a marker of DNA synthesis, which was supported by BrdU
incorporation assay (Fig. 1B). Another protein that interacts with Akt
and affects the proliferation of cells is PA2G4 that can bind to the
androgen receptor [44] and transcriptionally repress genes regulated
by the receptor [45]. Overexpression of PA2G4 has been reported to
inhibit growth in LNCaP human prostate adenocarcinoma cells [45],
NIH3T3 human ﬁbroblasts [46] and rat pheochromocytoma PC-12
cells [47]. Thus, the observed increased expression of PA2G4 in A549
mediated by CB exposure can be another marker that suppresses cell
proliferation. In essence A549 cellular proteomic changes relevant to
CB exposure involved in reduction in cell proliferation are consistent
with the level of BrdU incorporation.
Toxicoproteomics also revealed particle-speciﬁc changes in the level
and/or direction of a unique set of proteins that are known to regulate
cell death (apoptosis and necrosis) (Table 3). In the protein-protein
interaction network of the cell death pathway in Fig. 5, about a dozen
of A549 proteins showed a stark difference between TiO2 and CB
exposures. For example, TiO2 speciﬁcally increased the expression of
TRIM28 and FUBP1 but decreased the expression of ALDH1A1, CCT2,
LMNA and TMOD3. On the other hand, CB speciﬁcally decreased the
expression of TRIM28 and FUBP1 but increased the expression of
CAPZA1, CCT2, CCT6A, HSPA5, LMNA, PA2G4 and VCP. A number of
these proteins can also be found in the cell proliferation network as
these proteins have anti-proliferative effect as discussed above.
Interestingly, CB appears to cause more cell death in A549 cells than
TiO2 based on the LDH assay (Fig. 1A), but the variance in this assay
did not allow statistical analysis to differentiate the toxic potencies be-
tween the two particles. Thus, toxicoproteomics is more sensitive in
distinguishing the subtle effect of the particles on the cell death path-
ways. In addition, the VCP ATPase [48] and HSPA5 heat shock protein
[49] in the endoplasmic reticulum are associated with ATPase activity,
and thus CB-induced increases in VCP and HSPA5 can lower the level
of cellular ATP by enhancing ATPase activity in A549 cells. These ﬁnd-
ings were supported by ATP assay (Fig. 1C). In essence, the results of
our study demonstrated that toxicoproteomics is a sensitive and infor-
mative method to differentiate the toxic effects of particulate matter.
5. Conclusion
In vitro toxicoproteomics has the capacity to distinguish cellular
responses to two particles with distinct chemical and physical
properties as illustrated by TiO2 and CBexposures of A549 cells. The par-
ticles caused common and distinct A549 cellular responses that were
detectable via cytotoxicity assays and high-content proteomic analysis,which can be useful to investigate themolecularmechanisms of particle
toxicity. This toxicoproteomic approach can be valuable in future
particle toxicity evaluation studies.
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